Epidermal growth factor receptor inhibitors: a patent review (2010 - present).

about

Transcriptional changes associated with resistance to inhibitors of epidermal growth factor receptor revealed using metaanalysis.Utilization of Structure-Based Design to Identify Novel, Irreversible Inhibitors of EGFR Harboring the T790M Mutation.

P2860

Q35604127-B2DE31C5-019A-4080-A244-091FA15F89A7 Q42787494-57A9F7E2-887D-4A22-A0AB-8657A9559683

P2860

Epidermal growth factor receptor inhibitors: a patent review (2010 - present).

Item

http://www.wikidata.org/entity/Q38175432

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Epidermal growth factor receptor inhibitors: a patent review (2010 - present).

@en

type

Item

label

Epidermal growth factor receptor inhibitors: a patent review (2010 - present).

@en

prefLabel

Epidermal growth factor receptor inhibitors: a patent review (2010 - present).

@en

P1476

Epidermal growth factor receptor inhibitors: a patent review (2010 - present).

@en

P2093

Huan-Qiu Li

http://www.w3.org/2001/XMLSchema#string

Si-Ning Li

http://www.w3.org/2001/XMLSchema#string

P2860

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

Micronutrient sprinkles to control childhood anaemia

Structure-guided development of affinity probes for tyrosine kinases using chemical genetics

Structural insights into how irreversible inhibitors can overcome drug resistance in EGFR

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

Fast-forwarding hit to lead: aurora and epidermal growth factor receptor kinase inhibitor lead identification

Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Untangling the ErbB signalling network

P304

309-321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.2014.871527

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24387079

http://www.w3.org/2001/XMLSchema#string

Epidermal growth factor receptor inhibitors: a patent review (2010 - present).

about

P2860

P2860

Epidermal growth factor receptor inhibitors: a patent review (2010 - present).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698